Advertisement

Brain

  • John L. Darling
Part of the Developments in Oncology book series (DION, volume 64)

Abstract

A majority of malignant gliomas yield vigorous short-term cultures which are apparently derived from the tumour cells and not stroma. In a high proportion of cases, perhaps 30-40%, these short-term lines will give rise to established cell lines. It is the purpose of this review to examine the current methodology for preparing short-term cultures from malignant glioma and the other major types of intracranial tumours and some of the characteristics of such cultures.

Keywords

Glioma Cell Malignant Glioma Human Glioma Glioma Cell Line Human Brain Tumour 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ambrose, E.J., Batzdorf, U. and Easty, D.M. (1972). Morphology of astrocytomas in tissue culture: optical and stereoscan microscopy. J. Neuropath. exp. Neurol. 31: 596–610.PubMedGoogle Scholar
  2. Aoki A. 1974. Long-term serial cell cultivation of human brain tumor in vitro. Tohoku J. exp. Med. 112 225–239Google Scholar
  3. Barker, M., Wilson, C.B. and Hoshino, T. (1972). Tissue culture of human brain tumors. In: Kirsch, W.M., Grossi-Paoletti, E., and Paoletti, P. (eds). The experimental biology of brain tumors. Charles C. Thomas, Springfield, Illinois. pp. 57–84.Google Scholar
  4. Benediktsson, G., Carlsson, J., Nilsson, S., Jakobsson, P.A. and Ponten J. (1983). The detachment, attachment and growth capacity of human glioma and glia cells in culture. Ada. Path. Microbiol. Immunol. Scand. (Sect. A) 91: 291–296.Google Scholar
  5. Bigner, S.H., Mark, J., Mahaley, M.S. and Bigner, D.D. (1984). Patterns of the early, gross chromosomal changes in malignant gliomas. Hereditas. 101: 103–113.PubMedGoogle Scholar
  6. Bigner, D.D., Bigner, S.H., Ponten, J., Westermark, B., Mahaley, M.S. Jr., Ruoslahti, E., Herschman, H., Eng, L.F. and Wikstrand, C.J. (1981). Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J. Neuropath. Exp. Neurol. 40: 201–229.PubMedGoogle Scholar
  7. Bigner, S.H., Bjerkvig, R. and Laerum, O.D. (1985). DNA content and chromosomal composition of malignant gliomas. Neurol. Clin. 3: 769–784.PubMedGoogle Scholar
  8. Caine, G.D., Weller, R.O, Davis, B.E. and Cox, S. (1980). Mechanisms of uptake and the fate of serum proteins and horseradish peroxidase in cultured human glioma cells. Acta. Neuropathol. (Berl) 52: 169–177.Google Scholar
  9. Chaurasiya, J., Mohanty, S. and Prasad, G.C. (1980). Cell growth rate of human brain tumours in vitro. Ind. J. Med. Res. 71: 124–128.Google Scholar
  10. Chen, T.T. and Mealey, J. (1970). Microculture of human brain tumors. Cancer Chemother. Rep. 54: 9–14.PubMedGoogle Scholar
  11. Collins, V.P. (1983). Cultured human glial and glioma cells. Int. Rev. Exp. Pathol. 24: 135–202.PubMedGoogle Scholar
  12. Cook, A.W, Nidzgorski, F., Roane, P.R., Mann, G., Came, P. and Carter, W.A. (1987). Human non-malignant and malignant brain tumour derived cell cultures: proliferation and sensitivity to natural human fibroblast (beta) interferon. J Neuro-oncol 4: 337–344.Google Scholar
  13. Courtenay, V.D. (1984). A replenishable soft agar colony assay for human tumour sensitivity testing. Recent. Results in Cancer Research 94: 17–34.Google Scholar
  14. Cravioto, H. (1986). Human and experimental gliomas in tissue culture. Prog. Neuropathol. 6: 165–188.Google Scholar
  15. Darling, J.L. (1990) The in-vitro biology of human brain tumours. In: Thomas, D.G.T. (ed.) Neuro-oncology. Edward Arnold, London, pp. 1–26.Google Scholar
  16. Duffy, P.E., Huang, Y-Y, and Rapport, M.M. (1982). The relationship of glial fibrillary acidic protein to the shape, motility, and differentiation of human astrocytoma cells. Exp. Cell Res. 139: 145–157.PubMedGoogle Scholar
  17. Escalona-Zapata, J. and Diez-Nau, M.D. (1981). The astrocytic nature of glioblastoma demonstrated by tissue culture. Acta Neuropath. (Berl) 53: 155–160.Google Scholar
  18. Frame, M.C., Freshney, R.I., Vaughan, P.F.T., Graham, D.I. and Shaw, R. (1984). Interrelationship between differentiation and malignancy associated properties in glioma. Br. J. Cancer. 49: 269–280.PubMedGoogle Scholar
  19. Franks, A. J. and Burrow, H.M. (1986). In vitro heterogeneity in human gliomas. Are all transformed cells of glial origin? Anticancer Res. 6: 625–630.PubMedGoogle Scholar
  20. Freshney, R.I. (1976). Preparation of primary cell cultures. In Dendy, P.P. (ed) Human tumours in short term culture: Techniques and clinical applications. Academic Press, London. pp. 20–22.Google Scholar
  21. Freshney, R.I. and Hart, E. (1982). Clonogenicity of human glia in suspension. Br. J. Cancer 46: 463.Google Scholar
  22. Friedman, H.S., Burger, P.C., Bigner, S.H., Trojanowski, J.O., Wikstrand, C.J., Haplerin, E.C., and Bigner, D.D. (1985). Establishment and characterisation of the human medulloblastoma cell line and transplantable xenograft, D283 Med. J. Neuropath. Exp. Neurol. 44: 592–605.PubMedGoogle Scholar
  23. Green, S.B., Byar, D.P., Walker, M.D. and fifteen others (1983). Comparisons of carmustine, procarbazine and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat. Rep. 67: 121–132.PubMedGoogle Scholar
  24. Guner, M., Freshney, R.I., Morgan, D., Freshney, M.G. Thomas, D.G.T. and Graham, D.I. (1977). Effects of dexamethasone and betamethasone on in vitro cultures from human astrocytoma. Br. J. Cancer. 35: 439–447.PubMedGoogle Scholar
  25. Haynes, L.W., and Weller, R.O. (1978). The effects of cytochalasin B and colchicine on cell motility and ultrastructure in primary cultures of malignant gliomas. Acta. Neuropathol. (Berl) 44: 21–30.Google Scholar
  26. Icard, C., Liepkalns, V.A., Yates, A.J., Singh, N.P., Stephens, R.E. and Hart, R.W. (1981). Growth characteristics of human glioma-derived and foetal neural cells in culture. J. Neuropath. Expl. Neurol. 40: 512–525.Google Scholar
  27. Jacobsen, P.F., Jenkyn, D.J., and Papadimitriou, J.M. (1985). Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice. J. Neuropath. Exp. Neurol. 44: 472–485.PubMedGoogle Scholar
  28. Jacobsen, P.F., Jenkyn, D.J., and Papadimitriou, J.M. (1987). Four permanent cell lines established from human malignant gliomas: Three exhibiting striated muscle differentiation. J. Neuropath. Exp. Neurol. 46: 431–450.PubMedGoogle Scholar
  29. Kennedy, P.G.E., Watkins, B.A., Thomas, D.G.T. and Noble, M.D. (1987). Antigenic expression by cells derived from human gliomas does not correlate with morphological classification. Neuropath. Appl. Neurobiol. 13: 327–347.Google Scholar
  30. Kennedy, P.G.E. (1982). Neural cell markers and their applications to neurology. J. Neuroimmunology. 2: 35–53.Google Scholar
  31. Kersting, G. (1968). Tissue culture of human gliomas. Prog. Neurol. Surg. 2: 165–202.Google Scholar
  32. Koga, H. (1985). Study of the motility and contractility of cultured brain tumor cells. J. Neurosurg. 62: 906–911.PubMedGoogle Scholar
  33. Korsgaard, R., Clausen, O.P.F. and Thorud, E. (1984). Establishment of a human meningeal cell line in culture. Anticancer Research, 4: 83–9PubMedGoogle Scholar
  34. Lee, W-H., Yeh, M-Y., Tu, Y-C., Hau, S-H. and Wang, Y-C. (1988). Establishment and characterisation of a malignant glioma cell line, GBM 8401/ TSGH, NDMC. J. Surg. Oncol. 38: 173–181.PubMedGoogle Scholar
  35. Lolait, S.J., Harmer, J.H., Anteri, G., Pedersen, J.S. and Toh, B.H. (1983) Expression of glial fibrillary acidic protein, actin, fibronectin and factor VIII antigen in human astrocytomas. Pathology. 15: 373–378.PubMedGoogle Scholar
  36. Lumsden, C.E. (1971). The study by tissue culture of tumours of the nervous system. In: Russell, D.S. and Rubinstein, L.J. (eds). Pathology of tumours of the nervous system, 3rd Edition. Edward Arnold, London. pp. 334–420.Google Scholar
  37. Manuelidis, E.E. (1965). Long term lines of tissue cultures of intracranial tumours. J. Neurosurg. 22: 368–373.PubMedGoogle Scholar
  38. Maunoury, R. (1977). Establishment and characterisation of 5 human cell lines derived from a series of 50 primary intracranial tumours. Acta Neuropathol. (Berl) 39: 33–41.Google Scholar
  39. McKeever, P.E. and Chronwall, B.M. (1985). Early switch in glial protein and fibronectin markers on cells during the culture of human gliomas. Ann N. Y. Acad. Sci. 435: 457–459.Google Scholar
  40. McKeever, P.E., Hood, T.W., Varani, J., Taren, J.A., Beierwaltes, W.H., Wahl, R., Lievert, M. and Nguyen, P.K. (1987). Products of cells cultured from gliomas V: Cytology and morphometry of two cell types cultured from glioma. J.N.C.I. 78: 75–84.Google Scholar
  41. McKeever, P.E., Fligiel, S.E. and Varani, J. (1986). Products of cells cultured from gliomas IV: Extracellular matrix proteins of gliomas. Int. J. Cancer 37: 867–874.PubMedGoogle Scholar
  42. Miyake, E. (1979). Establishment of a human oligodendroglial cell line. Acta. Neuropathol. (Berl) 46: 51–55.Google Scholar
  43. Morgan, D., Freshney, R.I., Darling, J.L., Thomas, D.G.T. and Celik, F. (1983). Assay of anticancer drugs in tissue culture: Cell cultures from biopsies of human astrocytoma. Br. J. Cancer. 47: 205–214.PubMedGoogle Scholar
  44. Pertuiset, B., Dougherty, D., Cromeyer, C., Hoshino, T., Berger, M. and Rosenblum, M.L. (1985). Stem cell studies of human malignant brain tumors. Part 2. Proliferation kinetics of brain tumour cells in vitro in early passage culture. J. Neurosurg. 63: 426–432.PubMedGoogle Scholar
  45. Ponten, J., Westermark, B. and Hugosson, R. (1969). Regulation of proliferation and movement of human glia-like cells in culture. Exp. Cell Res. 58: 393–400.PubMedGoogle Scholar
  46. Ponten, J. and Macintyre, E.H. (1968). Long-term culture of normal and neoplastic human glia. Acta. Path. Microbiol. Scand. 74: 465–486.PubMedGoogle Scholar
  47. Ponten, J. (1973). Human glia cells. In: Kruse, P.F. and Patterson, M.K. (eds.) Tissue culture, methods and applications. Academic Press, New York, pp. 50–53.Google Scholar
  48. Rosenblum, M.L., Gerosa, M.A., Wilson, C.B., Barger, G.R., Pertuiset, B.F., de Tribolet, N. and Dougherty, D.V. (1983). Stem cell studies of human malignant brain tumors. Part 1. Development of the stem cell assay and its potential. J. Neurosurg. 58: 170–176.PubMedGoogle Scholar
  49. Russell, D.S. and Rubinstein, L.J. (1977). Pathology of tumours of the nervous system. 4th Ed. Edward Arnold, LondoGoogle Scholar
  50. Rutka, J.T., Giblin, J.R., Dougherty, D.V., Liu, H.C., McCulloch, J.R., Bell, C.W., Stern, R.S., Wilson, C.B. and Rosenblum, M.L. (1987). Establishment and characterisation of five cell lines derived from human malignant gliomas. Acta. Neuropathol. (Berl) 75: 92–103.Google Scholar
  51. Rutka, J.T., Giblin, J.R., Hoitodt, H.K., Dougherty, D.V., Bell, C.W., McCulloch, J.R., Davis, R.L., Wilson, C.B. and Roseblum, M.L. (1986). Establishment and characterisation of a cell line from a human gliosarcoma. Cancer Res. 46: 5893–5902.PubMedGoogle Scholar
  52. Sherbet, G.V., Tindle, M.E. and Stidolph, S. (1982). Fibronectin in human astrocytomas grown in tissue culture. Anticancer Res. 2: 251–254.PubMedGoogle Scholar
  53. Sherbet, G.V. and Lakshmi, M.S. (1974). The surface properties of some human intracranial tumour cell lines in relation to their malignancy. Oncology 29: 335–347.PubMedGoogle Scholar
  54. Stratton, M.R., Darling, J., Lantos, P.L., Cooper C.S. and Reeves, B.R. (1989). Cytogenetic abnormalities in human ependymomas. Int. J. Cancer, 44: 579–58PubMedGoogle Scholar
  55. Studer, A., de Tribolet, N., Diserens, A.C., Guide, A.C., Matthieu, J.M., Carrel, S., and Stavrou, D. (1985). Characterisation of four human malignant glioma cell lines. Acta. Neuropath. (Berl) 66: 208–217.Google Scholar
  56. Thomas, D.G.T., Darling, J.L., Paul, E.A., Mott, T.J., Godlee, J.N., Tobias, J.S., Capra, L., Collins, C.D., Mooney, C., Bozek, T., Finn, G.P., Arigbabu, S.O., Bullard, D.E., Shannon, N. and Freshney, R.I. (1985). Assay of anticancer drugs in tissue culture: Prediction of relapse free interval in patients with malignant cerebral glioma using an in vitro chemosensitivity assay. Br. J. Cancer. 51: 525–532.PubMedGoogle Scholar
  57. Thomas D.G.T. Darling J.L. Watkins B.A. and Hine M.C. 1984. A simple method for the growth of cell cultures from small biopsies of brain tumours taken during CT-directed stereotactic procedures. Acta. Neurochir. Suppl. 33 177–181Google Scholar
  58. Tveit, K.M. (1983). Evaluation of the Courtenay assay for drug sensitivity prediction in vivo. In: Dendy, P.P. and Hill, B.T. (eds.) Human tumour drug sensitivity testing in vitro: Techniques and clinical applications. Academic Press, London, pp. 305–315.Google Scholar
  59. Unterharnscheidt, F.J. (1972). Routine tissue culture of CNS tumors and animal implantation. Prog. exp. Tumour Res., 17: 111–150Google Scholar
  60. Von Hoff, D.D., Swenerton, K.D., Hetanen, L., Gafney, E., Rivkin, S., Schuchart, S. and Coltman, C.A. (1982). Long distance transportation of specimens for human tumour cloning. Stem Cells 2: 122–128.Google Scholar
  61. Waghe, M., Kumar, S. and Steward, J.K. (1973). Tissue culture studies of children’s tumours. J. Pathol. 111: 117–124.PubMedGoogle Scholar
  62. West, G.M., Vaughan, P.F.T., Freshney, R.I., McNamee, H.B. and Graham, D.I. (1982). Isolation of primary cultures from post-mortem samples of human brain. Biochem. Soc. Trans. 10: 53–54.Google Scholar
  63. Westermark, B., Larsson, E., Brunk, U., Lubitz, W. and Mark, J. (1981). Establishment of attached and non-attached cell lines from an uncommon human glioma. Int. J. Cancer 28: 341–351.PubMedGoogle Scholar
  64. Westermark, B., Ponten, J. and Hugosson, R. (1973). Determinants for the establishment of permanent tissue culture lines from human gliomas. Acta. Path. Microbiol. Scand. (Section A) 81: 791–805.Google Scholar
  65. Wilson, C.B., Barker, M. and Slagel D.E. (1966). Tumors of the central nervous system in monolayer tissue. Arch. Neurol. 15: 275–282.PubMedGoogle Scholar
  66. Yang, X., Darling, J.L., McMillan, T.J., Peacock, J.H. and Steel, G.G. (1990). Radiosensitivity, recovery and dose-rate effect in three human glioma cell lines. Radiother. Oncol., 19: 49–56PubMedGoogle Scholar
  67. Yang, X., Darling, J.L., McMillan, T.J., Peacock, J.H. and Steel, G.G. (1991). Heterogeneity of radiosensitivity in a human glioma cell line. Int J. Radiat. Oncol. Biol. Phys., in press.Google Scholar
  68. Yung, W-K.A., Rankin, J.K. and Shapiro, W.R. (1980). Glial filaments in human glioma cells in culture. J Cell Biol. 87: 181a.Google Scholar
  69. Zupi, G., Candiloro, A., Laudonio, N., Carapella, C., Benassi, M., Riccio, A., Bellocci, M. and Creco, C. (1988). Establishment, characterization and chemosensitivity of two human glioma derived cell lines. J. Neuro-oncol. 6: 169–177.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1991

Authors and Affiliations

  • John L. Darling

There are no affiliations available

Personalised recommendations